[Myocardial perfusion scintigraphy 2008 in Germany - results of the fourth query].
OBJECTIVE
The working group Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine in cooperation with the working group Nuclear Cardiology of the German Cardiac Society herewith present the results of the 4th survey on myocardial perfusion scintigraphy (MPS) of the year 2008.


METHODS
310 questionnaires (191 private practices (PP), 93 hospitals (HO), 31 university hospitals (UH)) were evaluated.


RESULTS
MPS of 98947 patients were reported. 15% of them were younger than 50 y, 57% between 50 and 70 y and 28% older than 70 y. 88% [2007: 83%] of all were studied with Tc-99m perfusion tracers. The patient radiation exposure of a stress and rest protocol considering German standard recommended doses was 8.5 mSv, of a stress-only protocol 1.9 mSv. 77% [2007: 76%] of the MPS were performed in PP, 15% [2007: 15%] in HO and 8% [2007: 9%] in UH. From 2005 to 2008 there was a mild increase in the MPS numbers by 1.2% (PP +7.1%, HO -5.5%, UH -31.4%). The type of stress was pharmacological in 30% [2007: 27%]; 68% adenosine (of these 22% with exercise), 29% dipyridamole (of these 64% with exercise), and <1% dobutamine. Gated SPECT was performed in 46% [2007: 47%] of all rest and in 42% [2007: 44%] of all stress MPS. 62% [2007: 61%] of all institutions did not use perfusion scores.


CONCLUSIONS
The MPS numbers from 2005 to 2008 in Germany can be regarded as stable. However, there are considerable shifts from HO and UH to PP. The well known potential of MPS considering risk stratification and functional analysis has not been tapped so far. Both gated SPECT and a quantitative perfusion analysis should be performed routinely in every patient.
Lindner
O
O
Institut für Radiologie, Nuklearmedizin und Molekulare Bildgebung, Herz- und Diabeteszentrum NRW, Georgstr. 11, 32545 Bad Oeynhausen, Germany. olindner@hdz-nrw.de
Burchert
W
W
Bengel
F M
FM
Zimmermann
R
R
Vom Dahl
J
J
Schäfer
W
W
Schober
O
O
Schäfers
M
M
D000241:Adenosine; D000368:Aged; D004176:Dipyridamole; D004280:Dobutamine; D005858:Germany; D006761:Hospitals / Q000706:statistics & numerical data; D006785:Hospitals, University / Q000706:statistics & numerical data; D006801:Humans; D008875:Middle Aged; D055414:Myocardial Perfusion Imaging / Q000706:statistics & numerical data*; D011331:Private Practice / Q000706:statistics & numerical data; D019275:Radiopharmaceuticals; D012955:Societies, Medical; D011795:Surveys and Questionnaires; D013667:Technetium; D015899:Tomography, Emission-Computed, Single-Photon / Q000706:statistics & numerical data
D019275:Radiopharmaceuticals; D004280:Dobutamine; D004176:Dipyridamole; D013667:Technetium; D000241:Adenosine